Studies related to Ferritin and Curcumin

Highly Bioavailable Micellar Curcuminoids Accumulate In Blood, Are Safe And Do Not Reduce Blood Lipids And Inflammation Markers In Moderately Hyperlipidemic Individuals

Effect None
Values (ug/L). Placebo: before 145 ± 15, after 138 ± 151. Curcumin: before 150 ± 161, after 142 ± 160
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 42
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Body Types Obese, Overweight, Average
Notes for this study:
In a randomized, double-blind, placebo-controlled crossover trial, 42 participants with moderate hyperlipidemia were assigned to take 294.2 mg of micellar curcuminoids or placebo daily for 6 weeks, with 4 weeks of washout between the two conditions.

When taking curcumin, there was no statistically significant difference between groups for total cholesterol, triglycerides, LDL-C, HDL-C, c-reactive protein or IL-6 levels. There was also no statistically significant difference betwen groups for fasting glucose, insulin, or insulin resistance, and no differences in iron metabolism, body weight, or the liver enzymes AST and ALt.

Full details on all 1 studies are available to Examine Plus members.

Already a member? Login now to access.